Product Information
NORVASC 5 MG TABLET is a brand product labeled by Pfizer Inc., priced at $8.6931 per EA under NDC 00069153072. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jul 31, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the amlodipine besylate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Pfizer Inc.NDC
00069153072
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMLODIPINE BESYLATEApproval Type
New Drug (NDA)
FDA Application
NDA019787FDA Approved
7/31/1992
TE Code
AB
On Market Since
7/31/1992
Pharmacological Classes
Price Statistics
The NADAC for NORVASC 5 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 202.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.6931 per EA |
|---|---|
| All-time high | $8.6976 (Sep 16, 2026) |
| All-time low | $2.8749 (Nov 28, 2013) |
| 52-week high | $8.6976 |
| 52-week low | $8.2691 |
| Median price | $6.5565 |
| Average price | $6.2564 |
| Largest weekly change | +12.0% (Jan 4, 2017) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pfizer Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
amlodipine besylate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NORVASC 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NORVASC 5 MG TABLET, manufactured by Pfizer Inc., is $8.6931 per EA (NDC 00069153072), effective Sep 30, 2026.
How has the price of NORVASC 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for NORVASC 5 MG TABLET has risen 202.4%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NORVASC 5 MG TABLET?
Since Nov 28, 2013, the NADAC for NORVASC 5 MG TABLET has ranged from a low of $2.8749 (Nov 28, 2013) to a high of $8.6976 (Sep 16, 2026), with a median of $6.5565 per EA.
Are there cheaper alternatives to NORVASC 5 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMLODIPINE BESYLATE 5 MG TAB, is $0.0102 per EA — about 99% below NORVASC 5 MG TABLET.
Who manufactures NORVASC 5 MG TABLET?
NORVASC 5 MG TABLET (NDC 00069153072) is labeled by Pfizer Inc., and CMS classifies it as a brand product.